Sertraline
- Generic Name
- Sertraline
- Brand Names
- Zoloft
- Drug Type
- Small Molecule
- Chemical Formula
- C17H17Cl2N
- CAS Number
- 79617-96-2
- Unique Ingredient Identifier
- QUC7NX6WMB
- Background
Sertraline is a popular antidepressant medication commonly known as a selective serotonin reuptake inhibitor (SSRI), and is similar to drugs such as Citalopram and Fluoxetine. Despite marked structural differences between compounds in this drug class, SSRIs exert similar pharmacological effects.
...
- Indication
Sertraline is indicated for the management of major depressive disorder (MDD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), panic disorder (PD), premenstrual dysphoric disorder (PMDD), and social anxiety disorder (SAD). Common off-label uses for sertraline include the prevention of post stroke depression, generalized anxiety di...
- Associated Conditions
- Binge Eating Disorder (BED), Bulimia Nervosa, Generalized Anxiety Disorder, Major Depressive Disorder (MDD), Obsessive Compulsive Disorder (OCD), Panic Disorder, Post Traumatic Stress Disorder (PTSD), Premenstrual Dysphoric Disorder (PMDD), Social Anxiety Disorder (SAD)
- Associated Therapies
- -
NMDA Modulation in Major Depressive Disorder in Late- Life
- Conditions
- Interventions
- First Posted Date
- 2018-01-30
- Last Posted Date
- 2020-12-01
- Lead Sponsor
- Chang Gung Memorial Hospital
- Target Recruit Count
- 136
- Registration Number
- NCT03414931
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
🇨🇳Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Specifying and Treating Anxiety in Autism Research
- Conditions
- Interventions
- First Posted Date
- 2017-09-12
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 68
- Registration Number
- NCT03279471
- Locations
- 🇺🇸
UC Davis MIND Institute, Sacramento, California, United States
Study of the Effect of Antidepressant Drugs on Neurotrophic Factors in Patients With Depression
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2018-07-11
- Target Recruit Count
- 105
- Registration Number
- NCT03126188
- Locations
- 🇮🇳
Dept of Psychiatry, Aiims, Bhubaneswar, Bhubaneswar, Odisha, India
A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD)
- Conditions
- Interventions
- First Posted Date
- 2017-01-26
- Last Posted Date
- 2021-12-08
- Target Recruit Count
- 336
- Registration Number
- NCT03033069
- Locations
- 🇺🇸
Investigational Site, Everett, Washington, United States
Cryptococcal Antigen Screening Plus Sertraline
- Conditions
- Interventions
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2020-06-09
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 22
- Registration Number
- NCT03002012
- Locations
- 🇺🇬
Infectious Disease Institute, Makerere University, Kampala, Uganda
CAMH - McMaster Collaborative Care Initiative For Mental Health Risk Factors In Dementia
- Conditions
- Interventions
- First Posted Date
- 2016-11-04
- Last Posted Date
- 2021-01-07
- Lead Sponsor
- Centre for Addiction and Mental Health
- Target Recruit Count
- 145
- Registration Number
- NCT02955719
- Locations
- 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's Disease
- Conditions
- Interventions
- First Posted Date
- 2016-09-28
- Last Posted Date
- 2021-10-20
- Lead Sponsor
- National Cheng-Kung University Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT02917122
Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode
- Conditions
- Interventions
- First Posted Date
- 2016-09-28
- Last Posted Date
- 2020-11-20
- Lead Sponsor
- Federal University of Rio Grande do Sul
- Target Recruit Count
- 78
- Registration Number
- NCT02918097
Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis
- First Posted Date
- 2016-09-20
- Last Posted Date
- 2022-03-21
- Lead Sponsor
- University of California, San Francisco
- Registration Number
- NCT02908334
Cost- Effectiveness and Quality of Life Assessment in Major Depression Disorder
- First Posted Date
- 2016-09-15
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- Federal University of Rio Grande do Sul
- Target Recruit Count
- 68
- Registration Number
- NCT02901249
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.